Influence of social norms on attitudes towards COVID-19 vaccination

How to cite

Rittmannsberger, Thomas; Lergetporer, Philipp; Angerer, Silvia; Glätzle-Rützler, Daniela. 2021. "Influence of social norms on attitudes towards COVID-19 vaccination." AEA RCT Registry. AEARCTR-0007457. https://doi.org/10.1257/rct.7457-3.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Thomas Rittmannsberger* , Philipp Lergetporer , Silvia Angerer , Daniela Glätzle-Rützler

* Primary investigator

Registry ID
AEARCTR-0007457
DOI
https://doi.org/10.1257/rct.7457-3.0
First registered
Last updated
Status
In development
Trial dates
2021-04-09 – 2022-12-31
Countries
Private
JEL codes
C93
Registry record
http://www.socialscienceregistry.org/trials/7457

Abstract

Despite the immense utility that anti-COVID-19 vaccines create for individuals and society at large, recent surveys show that about 25 to 42 percent of Germans do not intend to vaccinate against COVID-19. However, high uptake rates are crucial for achieving herd immunity. We investigate the extent to which individual vaccination intentions are affected by information about the social norm towards vaccination. In particular, we plan do conduct a representative survey in Germany that elicits respondents’ beliefs about the social norm regarding anti-COVID-19 vaccination. We then experimentally correctly potentially biased beliefs through factual information provision, and investigate how this affects attitudes towards anti-COVID-19 vaccination.

Intervention

We investigate whether providing citizens with representative information about the vaccination intentions of adults in Germany affects their intention to get the COVID-19-vaccine. Therefore, we plan to run an information provision experiment, where we provide respondents with information about social norms.
After eliciting beliefs about the social norm, we provide one group of participants with information about the norm, elicited in a prior survey, while the control group gets no additional information. Afterward we ask several questions concerning the respondents readiness to get vaccinated against COVID-19 as well as other vaccine-related questions.

Experimental design

We plan to sample a minimum of 2,000 adults aged between 18 and 69 years (up to a maximum of 3,000 — conditional on pending supplementary research funding; also see “Experiment characteristics”).
The survey is conducted in cooperation with a survey institute. The recruitment and polling are managed by the survey institute, which collects the data via an online platform. That is, our participants answer the survey questions autonomously on their own digital devices. Randomization is carried out by the survey institute at the individual level, using a computer.
Our experiment is structured as follows:
Respondents will be randomly assigned (between subject) to
Treatment 1 (p=0.5), or Treatment 2 (p=0.5).

Treatment 1:
Stage 1: Beliefs about social norms
[no Information-provision]
Stage 2: Intention to vaccinate — Index
Stage 3: Moderators and Mediators
Stage 4: Personal Questions & Time-, risk-, and social preferences

Treatment 2:
Stage 1: Beliefs about social norms
[Information about descriptive norm]
Stage 2: Intention to vaccinate — Index [+ info: descriptive norm]
Stage 3: Moderators and Mediators [+ info: descriptive norm]
Stage 4: Personal Questions & Time-, risk-, and social preferences

Design details

Randomization method
(e.g. public lottery, randomization done in office by a computer, coin flip): Randomization is carried out by the survey company, using a computer.
Randomization unit
at the individual level
Clusters
2,000 individuals (adults aged between 18 and 69 years). (maximum: 3,000 – conditional on pending supplementary research funding)
Observations
2,000 individuals (1,000 per treatment). (maximum: 3,000 (1,500/1,500) – conditional on pending supplementary research funding). According to our conservative cost calculations, we have sufficient funding for sampling 2,000 individuals. In case that we are granted supplementary research funding, we envisage to continue sampling up to a maximum number of 3,000 individuals.
Arms
1,000 per treatment (maximum 1,500/1,500 - conditional on pending supplementary research funding)
Primary outcomes
Intention to get vaccinated (5 outcomes), willingness to pay for the vaccine (2 outcomes), and normative social norm (2 outcomes). In our main analysis, we will create summary indices of these outcomes and estimate treatment effects on these indices. We will also investigate treatment effects on individual outcomes.
Secondary outcomes
Heterogeneity by prior beliefs; treatment effects on mediators and moderators (Q8 and Q9).

Cited by

No citation data available for this registration yet.

Keywords